We are live on ! Find out more
SER icon

Serina Therapeutics
SER

25 hedge funds and large institutions have $2.86M invested in Serina Therapeutics in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

248% more capital invested

Capital invested by funds: $822K → $2.86M (+$2.03M)

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

14% more funds holding

Funds holding: 22 → 25 (+3)

7.93% more ownership

Funds ownership: 4.03% → 11.96% (+7.9%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$2.2M
2
BlackRock
BlackRock
New York
+$90.3K
3
Jane Street
Jane Street
New York
+$87.3K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$76.1K
5
AWE
Avidian Wealth Enterprises
Texas
+$41.4K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadwood Capital
New York
-$104K
2
LW
Linscomb Wealth
Texas
-$36K
3
Northern Trust
Northern Trust
Illinois
-$26.9K
4
HighTower Advisors
HighTower Advisors
Illinois
-$22.9K
5
UBS Group
UBS Group
Switzerland
-$942
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$1.94M +$2.2M +1,000,000 New
VCM
2
Vanguard Capital Management
Pennsylvania
$309K +$350K +159,136 New
WA
3
Waverly Advisors
Alabama
$131K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$126K +$76.1K +34,564 +114%
BlackRock
5
BlackRock
New York
$113K +$90.3K +41,015 +238%
Jane Street
6
Jane Street
New York
$76.9K +$87.3K +39,653 New
KP
7
Keel Point
Alabama
$41.7K +$8.22K +3,734 +21%
VFT
8
Vanguard Fiduciary Trust
Pennsylvania
$38.8K +$44K +20,009 New
AWE
9
Avidian Wealth Enterprises
Texas
$36.5K +$41.4K +18,800 New
State Street
10
State Street
Massachusetts
$24.8K – – –
CIAM
11
Caitong International Asset Management
Hong Kong
$7.72K +$8.77K +3,982 New
Wells Fargo
12
Wells Fargo
California
$7K +$4 +2 +0.1%
Osaic Holdings
13
Osaic Holdings
Arizona
$1.94K +$2.2K +999 +49,950%
TRCT
14
Tower Research Capital (TRC)
New York
$1.64K +$867 +394 +88%
VGA
15
Vanguard Global Advisers
Pennsylvania
$714 +$810 +368 New
PSB
16
Piscataqua Savings Bank
New Hampshire
$54 – – –
ASN
17
Advisory Services Network
Georgia
$27 +$31 +14 New
AFG
18
Albion Financial Group
Utah
$16 – – –
Morgan Stanley
19
Morgan Stanley
New York
$16 – – –
PP
20
Pacifica Partners
Canada
$16 – – –
UBS Group
21
UBS Group
Switzerland
$10 -$942 -428 -99%
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$4 – – –
Rockefeller Capital Management
23
Rockefeller Capital Management
New York
$4 – – –
FFA
24
Farther Finance Advisors
California
$2 +$2 +1 New
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2 +$2 +1 New
1
2

SER Hedge Fund Activity: Q1 2026 in Review

25 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2026, worth a combined $2.86M — up 248% from $822K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SER positions and 5 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $2.2M. The largest seller was Broadwood Capital, exiting entirely with an estimated $104K sold.

  • 25 institutional investors held Serina Therapeutics (SER) as of Q1 2026, up from 22 in Q4 2025.
  • Funds reported $2.86M of Serina Therapeutics stock for Q1 2026, up 248% quarter-over-quarter.
  • 10 funds opened new Serina Therapeutics positions in Q1 2026 and 5 closed out, a net change of +5 holders.
  • The largest Serina Therapeutics buyer in Q1 2026 was Sio Capital Management, an estimated $2.2M added.
  • The largest Serina Therapeutics seller in Q1 2026 was Broadwood Capital, an estimated $104K sold.

Based on aggregated 13F filings for Q1 2026.